Although both full-length BCAN and BCAN HA binding domain (HABD) can promote invasion of glioma cells in non-neurogenic ECM, it seems that only HABD remains functional, promoting the invasion in brain ECM [159,214]. Here, BCAN is linked to central nervous system cancer.